Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Tuberculosis: A Retrospective Study on Clinical Features and a Diagnostic Model
The nine-predictor nomogram offers a useful preliminary screening tool for early differentiation, though external validation in multicenter studies is warranted.
Abstract
Background: Nontuberculous mycobacterial pulmonary disease (NTM-PD) and pulmonary tuberculosis (PTB) present with similar clinical and radiological features, frequently leading to misdiagnosis. This study aimed to compare NTM-PD with extrapulmonary NTM disease (ENTM) and PTB and to develop a predictive model for early differentiation. Methods: We retrospectively analyzed 473 NTM patients (340 NTM-PD, 112 ENTM, 21 disseminated) and 218 PTB patients treated between January 2008 and December 2024. A diagnostic model was developed using the Least Absolute Shrinkage and Selection Operator (LASSO) regression algorithm and multivariate logistic regression, with internal validation via 1000 bootstrap resamples and a pre-split validation cohort. Performance was evaluated by the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis. Results: Compared to ENTM, NTM-PD patients were older and had lower BMI, with bronchiectasis (OR = 24.86) and prior PTB history (OR = 7.58) as the strongest risk factors. Relative to PTB, NTM-PD patients were more often female and older, with more bronchiectasis and mucus plugs on imaging, while PTB showed more pleural thickening and effusion. NTM isolates exhibited high resistance to first-line anti-TB drugs but maintained susceptibility to macrolides and amikacin. The nine-predictor nomogram achieved AUCs of 0.758 (training) and 0.731 (validation), with calibration and decision curve analysis confirming clinical utility. Conclusions: NTM-PD and PTB exhibit distinct clinical, radiological, and microbiological profiles. The nomogram offers a useful preliminary screening tool for early differentiation, though external validation in multicenter studies is warranted.
Background and Clinical Significance: Pulmonary disease caused by nontuberculous mycobacteria (NTM) represents an important diagnostic challenge in tuberculosis-endemic settings because its clinical, radiological, and microbiological features may overlap with those of pulmonary tuberculosis (TB). Accurate distinction b...
The clinical presentation of PC is non-specific and cannot reliably differentiate immune status, underscoring the necessity of integrated laboratory and radiographic evaluation.
Juan Liao, Wen-Zhao Zhang, Li-Qing Peng et al.· Frontiers in Medicine· 0 citations
Background Nontuberculous mycobacterial lung disease (NTM-LD), a condition characterised by a heterogeneous course and complex multidrug treatment, is becoming an increasingly prevalent global health concern. Given that population-based data on real-world management and outcomes are limited, we aimed to characterise na...
Chih-Hao Chang, Yu-Feng Wei, Ping-Huai Wang et al.· Journal of Global Health· 0 citations
Objective This study sought to establish and externally validate an interpretable CT-based radiomics framework for early prediction of adverse disease progression in children with Mycoplasma pneumoniae pneumonia (MPP). Methods In this multicenter retrospective study, 419 children with MPP from three hospitals were assi...
Xiao-Yu Yao, Zheng-Fang Liu· Frontiers in Medicine· 0 citations
Elevated eosinophil levels decrease after anti-NTM treatment, accompanied by marked improvements in clinical symptoms and inflammatory markers, suggesting a potential correlation between eosinophil levels and treatment response.
Hao Sha, Hui Zhang, Jiehua Deng et al.· Frontiers in Cellular and In...· 0 citations
The neutrophil CD64 (nCD64) index has emerged as a promising biomarker for infection detection, but its evaluation within the mycobacterial infection spectrum remains limited. Here, we evaluated the diagnostic and treatment response performance of the nCD64 index in the active tuberculosis (ATB)—including pulmonary...
Yu-Xia Chen, Xu Ma, Lei Wang et al.· Frontiers in Microbiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.